Jolly Sanjit, Newton Gary, Horlick Eric, Seidelin Peter H, Ross Heather J, Husain Mansoor, Dzavik Vladimir
The Interventional Cardiology Program, Division of Cardiology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Am J Cardiol. 2005 Dec 15;96(12):1617-20. doi: 10.1016/j.amjcard.2005.07.076. Epub 2005 Oct 21.
In a retrospective study of 36 patients who developed cardiogenic shock after myocardial infarction, intravenous vasopressin therapy increased mean arterial pressure from 56 to 73 mm Hg at 1 hour (p < 0.001) and maintained it for 24 hours without changing pulmonary capillary wedge pressure, cardiac index, urine output, or other inotropic requirements. After norepinephrine administration, mean pulmonary capillary wedge pressure increased at 1 hour from 21 to 24 mm Hg (p = 0.04); however, this increase was not sustained at 12 and 24 hours. Norepinephrine was associated with a significant increase in cardiac power index at 24 hours, whereas there was only a trend for an increase in cardiac power with vasopressin therapy. In a cohort of patients who developed refractory cardiogenic shock after myocardial infarction, vasopressin was associated with increased mean arterial pressure and no adverse effect on other hemodynamic parameters.
在一项对36例心肌梗死后发生心源性休克患者的回顾性研究中,静脉注射血管加压素治疗使平均动脉压在1小时内从56毫米汞柱升至73毫米汞柱(p<0.001),并维持24小时,同时未改变肺毛细血管楔压、心脏指数、尿量或其他正性肌力药物的需求。给予去甲肾上腺素后,平均肺毛细血管楔压在1小时内从21毫米汞柱升至24毫米汞柱(p = 0.04);然而,这种升高在12小时和24小时时未持续。去甲肾上腺素与24小时时心脏功率指数显著升高相关,而血管加压素治疗时心脏功率仅呈上升趋势。在一组心肌梗死后发生难治性心源性休克的患者中,血管加压素与平均动脉压升高相关,且对其他血流动力学参数无不良影响。